A Phase I and Pharmacological Study with Imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent
RADEMAKER-LAKHAI, Jeany M, VAN DEN BONGARD, Desiree, PLUIM, Dick, BEIJNEN, Jos H, SCHELLENS, Jan H. M
Published in Clinical cancer research (01.06.2004)
Published in Clinical cancer research (01.06.2004)
Get full text
Journal Article
Intermittent versus continuous first-line treatment for HER2-negative metastatic breast cancer: the Stop & Go study of the Dutch Breast Cancer Research Group (BOOG)
Claessens, Anouk K. M., Bos, Monique E. M. M., Lopez-Yurda, Marta, Bouma, Jeanette M., Rademaker-Lakhai, Jeany M., Honkoop, Aafke H., de Graaf, Hiltje, van Druten, Edith, van Warmerdam, Laurence J. C., van der Sangen, Maurice J. C., Tjan-Heijnen, Vivianne C. G., Erdkamp, Frans L. G.
Published in Breast cancer research and treatment (01.11.2018)
Published in Breast cancer research and treatment (01.11.2018)
Get full text
Journal Article
Relationship Between Cisplatin Administration and the Development of Ototoxicity
RADEMAKER-LAKHAI, Jeany M, CRUL, Mirjam, ZUUR, Lot, BAAS, Paul, BEIJNEN, Jos H, SIMIS, Yvonne J. W, VAN ZANDWIJK, Nico, SCHELLENS, Jan H. M
Published in Journal of clinical oncology (20.02.2006)
Published in Journal of clinical oncology (20.02.2006)
Get full text
Journal Article
A Phase I and Pharmacological Study of the Platinum Polymer AP5280 Given as an Intravenous Infusion Once Every 3 Weeks in Patients with Solid Tumors
RADEMAKER-LAKHAI, Jeany M, TERRET, Catherine, HOWELL, Stephen B, BAUD, Christiane M, DE BOER, Richard F, PLUIM, Dick, BEIJNEN, Jos H, SCHELLENS, Jan H. M, DROZ, Jean-Pierre
Published in Clinical cancer research (15.05.2004)
Published in Clinical cancer research (15.05.2004)
Get full text
Journal Article
Phase I and pharmacokinetic trial of AP5346, a DACH-platinum-polymer conjugate, administered weekly for three out of every 4 weeks to advanced solid tumor patients
CAMPONE, Mario, RADEMAKER-LAKHAI, Jeany M, BENNOUNA, Jaafar, HOWELL, Stephen B, NOWOTNIK, David P, BEIJNEN, Jos H, SCHELLENS, Jan H. M
Published in Cancer chemotherapy and pharmacology (01.09.2007)
Published in Cancer chemotherapy and pharmacology (01.09.2007)
Get full text
Journal Article
Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Protein Kinase C β-Inhibitor Enzastaurin in Combination with Gemcitabine and Cisplatin in Patients with Advanced Cancer
RADEMAKER-LAKHAI, Jeany M, BEEREPOOT, Laurens V, VAN HAL, Gertjan, BEIJNEN, Jos H, SCHELLENS, Jan H. M, VOEST, Emile E, MEHRA, Niven, RADEMA, Sandra A, VAN MAANEN, Rianne, VERMAAT, Joost S, WITTEVEEN, Els O, VISSEREN-GRUL, Carla M, MUSIB, Luna, ENAS, Nathan
Published in Clinical cancer research (01.08.2007)
Published in Clinical cancer research (01.08.2007)
Get full text
Journal Article
Phase I Clinical and Pharmacokinetic Study of Kahalalide F in Patients with Advanced Androgen Refractory Prostate Cancer
RADEMAKER-LAKHAI, Jeany M, HORENBLAS, Simon, MEINHARDT, Willem, STOKVIS, Ellen, DE REIJKE, Theo M, JIMENO, José M, LOPEZ-LAZARO, Luis, LOPEZ MARTIN, José A, BEIJNEN, Jos H, SCHELLENS, Jan H. M
Published in Clinical cancer research (01.03.2005)
Published in Clinical cancer research (01.03.2005)
Get full text
Journal Article
Secondary analyses of the randomized phase III Stop&Go study: efficacy of second-line intermittent versus continuous chemotherapy in HER2-negative advanced breast cancer
Claessens, Anouk K. M., Erdkamp, Frans L. G., Lopez-Yurda, Marta, Bouma, Jeanette M., Rademaker-Lakhai, Jeany M., Honkoop, Aafke H., de Graaf, Hiltje, Tjan-Heijnen, Vivianne C. G., Bos, Monique E. M. M.
Published in Acta oncologica (02.06.2020)
Published in Acta oncologica (02.06.2020)
Get full text
Journal Article
The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancer
Claessens, Anouk K. M., Timman, Reinier, Busschbach, Jan J., Bouma, Jeanette M., Rademaker-Lakhai, Jeany M., Erdkamp, Frans L. G., Tjan-Heijnen, Vivianne C. G., Bos, Monique E. M. M.
Published in Breast cancer research and treatment (01.02.2020)
Published in Breast cancer research and treatment (01.02.2020)
Get full text
Journal Article
Metabolism of trabectedin (ET-743, Yondelis™) in patients with advanced cancer
BEUMER, Jan H, RADEMAKER-LAKHAI, Jeany M, ROSING, Hilde, HILLEBRAND, Michel J. X, BOSCH, Tessa M, LOPEZ-LAZARO, Luis, SCHELLENS, Jan H. M, BEIJNEN, Jos H
Published in Cancer chemotherapy and pharmacology (01.06.2007)
Published in Cancer chemotherapy and pharmacology (01.06.2007)
Get full text
Journal Article
Phase I clinical and pharmacologic study of a 2-weekly administration of cisplatin and gemcitabine in patients with advanced non-small cell lung cancer
Rademaker-Lakhai, Jeany M, Crul, Mirjam, Pluim, Dick, Sparidans, Rolf W, Baas, Paul, Beijnen, Jos H, van Zandwijk, Nico, Schellens, Jan H M
Published in Anti-cancer drugs (01.10.2005)
Published in Anti-cancer drugs (01.10.2005)
Get more information
Journal Article
Phase I and pharmacokinetic trial of AP5346, a DACH-platinum-polymer conjugate, administered weekly for three out of every 4weeks to advanced solid tumor patients
Campone, Mario, Rademaker-Lakhai, Jeany M, Bennouna, Jaafar, Howell, Stephen B, Nowotnik, David P, Beijnen, Jos H, Schellens, Jan HM
Published in Cancer chemotherapy and pharmacology (01.09.2007)
Published in Cancer chemotherapy and pharmacology (01.09.2007)
Get full text
Journal Article
Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Protein Kinase C {szligbeta}-Inhibitor Enzastaurin in Combination with Gemcitabine and Cisplatin in Patients with Advanced Cancer
Rademaker-Lakhai, Jeany M, Beerepoot, Laurens V, Mehra, Niven, Radema, Sandra A, van Maanen, Rianne, Vermaat, Joost S, Witteveen, Els O, Visseren-Grul, Carla M, Musib, Luna, Enas, Nathan, van Hal, Gertjan, Beijnen, Jos H, Schellens, Jan HM, Voest, Emile E
Published in Clinical cancer research (01.08.2007)
Get full text
Published in Clinical cancer research (01.08.2007)
Journal Article